Ionis Pharmaceuticals, Inc. (IONS)
84.78
-1.72
(-1.99%)
USD |
NASDAQ |
Feb 09, 16:00
83.28
-1.50
(-1.77%)
After-Hours: 20:00
Ionis Pharmaceuticals EPS Diluted (Quarterly) : -0.805 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Eli Lilly & Co. | 7.390 |
| Johnson & Johnson | 2.098 |
| Merck & Co., Inc. | 1.191 |
| Cogent Biosciences, Inc. | -0.5884 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -128.61M |
| Revenue (Quarterly) | 156.72M |
| Total Expenses (Quarterly) | 285.32M |
| Enterprise Value | 13.82B |
| Gross Profit Margin (Quarterly) | 96.67% |
| Profit Margin (Quarterly) | -82.06% |
| Earnings Yield | -2.02% |
| Normalized Earnings Yield | -2.065 |